Arbutus Biopharma(ABUS) - 2023 Q4 - Earnings Call Transcript

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Conference Call February 29, 2024 8:45 AM ET Company Participants Lisa Caperelli - VP, IR Michael McElhaugh - Interim President and CEO David Hastings - CFO and CAO Karen Sims - CMO Michael Sofia - CSO Conference Call Participants Dennis Ding - Jefferies Brian Skorney - Baird Roy Buchanan - Citizens JMP Thomas Yip - H.C. Wainwright Keay Nakae - Chardan Operator Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Fourth Quarte ...